News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Celano Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/18/2023 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $3.7263, valued at
$18.6k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 31,746 shares
@ $3.15, valued at
$100k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.92, valued at
$58.4k
|
|
| 01/20/2022 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $8.75, valued at
$700k
|
|
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2021 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 42,000 options to buy
@ $19.61, valued at
$823.6k
|
|
| 09/30/2020 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 84,100 options to buy
@ $11.9, valued at
$1M
|
|
| 06/05/2020 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 60,479 options to buy
@ $11.88, valued at
$718.5k
|
|
| 06/05/2020 |
3
| Celano Michael (CFO) has filed a Form 3 on Larimar Therapeutics, Inc. |
| 05/19/2020 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 3,843 shares
@ $16.0401, valued at
$61.6k
Granted 8,143 shares
@ $15.965, valued at
$130k
|
|
| 05/22/2019 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Granted 15,330 shares
@ $8.48, valued at
$130k
|
|
| 02/19/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/23/2019 |
4
| Celano Michael (COO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 12,672 shares
@ $0
Paid exercise price by delivering 1,782 shares
@ $7.99, valued at
$14.2k
Granted 60,592 options to buy
@ $7.99, valued at
$484.1k
Exercised 6,400 restricted stock units
@ $0 |
|
| 01/04/2019 |
4
| Celano Michael (COO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,702 shares
@ $7.41, valued at
$12.6k
|
|
| 05/15/2018 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 1,578 shares
@ $15.975, valued at
$25.2k
|
|
| 05/10/2018 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Granted 7,762 shares
@ $0 |
|
| 04/03/2018 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Granted 40,000 options to buy
@ $16.795, valued at
$671.8k
|
|
| 01/22/2018 |
4
| Celano Michael (COO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Paid exercise price by delivering 2,020 shares
@ $8.89, valued at
$18k
Exercised 6,400 restricted stock units
@ $0 |
|
| 01/04/2018 |
4
| Celano Michael (COO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $9.04, valued at
$361.6k
|
|
| 10/02/2017 |
4
| Celano Michael (CFO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Exercised 6,000 shares
@ $0
Paid exercise price by delivering 1,905 shares
@ $9.04, valued at
$17.2k
|
|
| 05/09/2017 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Sold 44,962 shares
@ $14.95, valued at
$672.2k
|
|
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2017 |
4
| Celano Michael (CFO) has filed a Form 4 on Recro Pharma, Inc. |
| 07/05/2016 |
4
| Celano Michael (CFO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 140,000 options to buy
@ $8.21, valued at
$1.1M
|
|
| 07/05/2016 |
3
| Celano Michael (CFO) has filed a Form 3 on Recro Pharma, Inc. |
| 05/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2016 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 4,177 shares
@ $6.835, valued at
$28.5k
|
|
| 06/26/2012 |
4
| Celano Michael (CFO) has filed a Form 4 on KENSEY NASH CORP|
Txns:
| Disposed/sold 2,500 shares
@ $38.5, valued at
$96.3k
Disposed/sold 20,200 rights
@ $25.64, valued at
$517.9k
Disposed/sold 30,000 options to buy
@ $17, valued at
$510k
Disposed/sold 4,400 options to buy
@ $28.48, valued at
$125.3k
Disposed/sold 12,000 options to buy
@ $28.98, valued at
$347.8k
|
|
| 02/03/2012 |
4
| Celano Michael (Director) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 4,210 shares
@ $11.295, valued at
$47.6k
Granted 8,854 shares
@ $0 |
|
|
|
|